Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
New Drug Application
Biotech
Milestone resubmits NDA, Aldeyra readies 2nd chance filing
Milestone Pharmaceuticals has resubmitted a new drug application to the FDA, with Aldeyra readying a similar ask for the second half of the year.
Max Bayer
Mar 28, 2024 10:40am
Tonix signs CRO deal, preps FDA app for fibromyalgia drug
Feb 14, 2024 12:52pm
First-ever drug application for MDMA finally reaches FDA
Dec 13, 2023 9:39am
Karuna's new schizophrenia drug reaches FDA's desk
Sep 28, 2023 11:12am
Beam's light scatters as FDA blocks phase 1 study for CAR-T
Aug 1, 2022 9:28am
Melinta pays Cidara $30M for antifungal pending FDA review
Jul 27, 2022 11:05am